+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Virology"

From
Primary Cell Culture Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Primary Cell Culture Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 145 Pages
  • Global
From
From
From
From
From
From
From
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 - Product Thumbnail Image

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

  • Report
  • October 2022
  • 348 Pages
  • Singapore, Malaysia, Indonesia Singapore, Malaysia, Indonesia
From
United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition - Product Thumbnail Image

United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition

  • Report
  • October 2022
  • 220 Pages
  • United States
From
Loading Indicator

Virology is a branch of biotechnology that focuses on the study of viruses and their effects on living organisms. It involves the study of the structure, function, and genetics of viruses, as well as their interactions with hosts. Virology also involves the development of vaccines and antiviral drugs to prevent and treat viral infections. Virology has become increasingly important in recent years due to the emergence of new and emerging viral diseases, such as Zika, Ebola, and SARS-CoV-2. Virologists are also involved in the development of gene therapy and gene editing technologies, which have the potential to revolutionize the treatment of many diseases. The virology market is highly competitive, with many companies offering products and services related to the study and treatment of viruses. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, and Gilead Sciences. Show Less Read more